GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40938)

  • GC91379 structure
    GC91379BDW568
    CAS: 335401-44-0
    Purity: >98.00%

    BDW568 es un agonista del gen estimulador de interferón (STING) y una forma de prodroga de BDW-OH.

  • GC91380 structure
    GC91380N6F11
    CAS: 851398-76-0
    Purity: >99.50%

    N6F11 es un inductor de la ferroptosis.

  • GC91389 structure
    GC91389J27644
    Purity: >95.00%

    J27644 es un inhibidor de la histona desacetilasa 6 (HDAC6; IC50 = 10 nM).

  • GC91391 structure
    GC91391Perfluoropentanesulfonic Acid
    CAS: 2706-91-4
    Purity: >95.00%

    El ácido perfluoropentanosulfónico es una sustancia perfluoroalquil (PFAS).

  • GC91397 structure
    GC91397N-desmethyl Levofloxacin (hydrochloride)
    Purity: >98.00%

    N-desmetil Levofloxacina es un metabolito activo del antibiótico fluoroquinolona levofloxacina.

  • GC91401 structure
    GC91401Neurofibrillary Tangle BODIPY (600/710 nm)
    CAS: 2301931-35-9
    Purity: >95.00%

    El BODIPY (600/710 nm) de enredo neurofibrilar es una sonda fluorescente para los enredos neurofibrilares (NFT).

  • GC91403 structure
    GC91403HR68
    CAS: 2454582-64-8
    Purity: >98.00%

    HR68 es un agente anticancerígeno y un derivado del agonista del receptor activado por el proliferador de peroxisomas (PPAR) ácido fenofíbrico.

  • GC91405 structure
    GC91405Perfluorohexanesulfonamide
    CAS: 41997-13-1
    Purity: >75.00%

    La perfluorohexanesulfonamida es una sustancia perfluoroalquilada (PFAS).

  • GC91406 structure
    GC91406UK 122 (trifluoroacetate salt)
    CAS: 1186653-73-5
    Purity: >95.00%

    UK 122 es un inhibidor del activador de plasminógeno tipo uroquinasa (uPA; IC50 = 0,2 µM).

  • GC91408 structure
    GC91408SLU-10482
    CAS: 2755451-45-5
    Purity: >98.00%

    SLU-10482 es un agente antiparasitario.

  • GC91409 structure
    GC91409Mandipropamid
    CAS: 374726-62-2
    Purity: >95.00%

    Mandipropamid es un fungicida de amida de ácido carboxílico.

  • GC91410 structure
    GC91410RA-2
    CAS: 1867107-62-7
    Purity: >95.00%

    RA-2 es un inhibidor del canal de potasio activado por calcio de conductancia pequeña 2.3 (KCa2.3/SK3) y del canal de potasio activado por calcio de conductancia intermedia 3.1 (KCa3.1/IK1) (IC50s = 2 y 17 nM, respectivamente).

  • GC91411 structure
    GC91411CT3
    CAS: 2403729-27-9
    Purity: >98.00%

    CT3 es un antiparasitario cianotriazol.

  • GC91417 structure
    GC91417Ipsapirone (hydrochloride)
    CAS: 92589-98-5
    Purity: >98.00%

    Ipsapirone es un agonista parcial del receptor de serotonina (5-HT) 5-HT1A (Ki = 10 nM en membranas hipocampales).

  • GC91418 structure
    GC91418(E)-KPT-330
    CAS: 1421923-86-5
    Purity: >99.00%

    (E)-KPT-330 es un metabolito del inhibidor de exportina 1 (XPO1/CRM1) selinexor.

  • GC91419 structure
    GC91419CYY292
    CAS: 2644673-04-9
    Purity: >98.00%

    CYY292 es un inhibidor de PDGFRα, PDGFRβ, FGFR1, -2 y -3 (IC50s = 5.35, 4.6, 28, 28 y 78 nM respectivamente).

  • GC91420 structure
    GC91420UNC7145
    CAS: 2561494-78-6
    Purity: >98.00%

    UNC7145 es un derivado inactivo del inhibidor de la histona-lisina N-metiltransferasa NSD2, UNC6934, que se ha utilizado como control negativo para la actividad metiltransferasa de histonas de NSD2.

  • GC91424 structure
    GC91424S1PL-IN-31
    CAS: 1538574-95-6
    Purity: >98.00%

    S1PL-IN-31 es un inhibidor de la lisofosfolipasa de esfingosina-1-fosfato (S1P) (IC50 = 210 nM).

  • GC91427 structure
    GC91427Glutaminase C Inhibitor 11
    Purity: >95.00%

    El inhibidor 11 de la glutaminasa C es un inhibidor de la glutaminasa C (GAC).

  • GC91430 structure
    GC91430RAD150
    CAS: 1208070-53-4
    Purity: >95.00%

    RAD150 es un modulador del receptor de andrógenos no esteroideo (IC50 = 130 nM) y un derivado de éster benzoato del modulador selectivo del receptor de andrógenos (SARM) RAD140.

  • GC91431 structure
    GC91431WDR5-MYC Probe 12
    Purity: >98.00%

    La sonda WDR5-MYC 12 es un inhibidor de la interacción proteína-proteína entre el factor de transcripción maestro Myc y el dominio repetido WD 5 (WDR5; IC50 = 0,39 µM).

  • GC91432 structure
    GC91432CAY10799
    CAS: 1423622-48-3
    Purity: >98.00%

    CAY10799 es un precursor en la síntesis de ligandos y sondas fluorescentes del antígeno de membrana específico de próstata (PSMA) que se han utilizado en la detección de PSMA en células LNCaP y PC3.

  • GC91434 structure
    GC91434N-ethyl Perfluorooctanesulfonamide
    CAS: 4151-50-2
    Purity: >85.00%

    N-etil Perfluorooctanesulfonamida (N-etil FOSA) es una sustancia perfluoroalquilada (PFAS) y un insecticida.

  • GC91435 structure
    GC91435YCH1899
    Purity: >98.00%

    YCH1899 es un inhibidor de la poli(ADP-ribosa) polimerasa 1 (PARP1) y PARP2 (IC50s = 1). Es selectivo para PARP1 y PARP2 sobre PARP3, -4, -5A, -5B, -6, -7, -10 y -12 (IC50s = 1-14.1 nM).